Inventor

KARAGEOZIAN VICKEN H

US11 patents

⚠️ This page may combine multiple inventors who share the name “KARAGEOZIAN VICKEN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ISTA PHARMACEUTICALS INC

2 patents

US6551590B2Apr 22, 2003

Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vireous body of the eye

ISTA PHARMACEUTICALS INC40 citations94

US6939542B2Sep 6, 2005

Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eye

ISTA PHARMACEUTICALS INC12 citations90

ALLEGRO PHARMACEUTICALS LLC

2 patents

US10590166B2Mar 17, 2020

Peptides useable for treating cancer

ALLEGRO PHARMACEUTICALS LLC3 citations70

US11673914B2Jun 13, 2023

Peptide therapies for reduction of macular thickening

ALLEGRO PHARMACEUTICALS LLC0 citations60

(unassigned)

1 patent

US5579201ANov 26, 1996

Modified electrical strip for energizing/de-energizing secondary devices simultaneously with a main device

119 citations96

ADVANCED CORNEAL SYSTEMS

1 patent

US6039943AMar 21, 2000

Method for accelerating clearance of hemorrhagic blood from the vitreous body with hyaluronidase

ADVANCED CORNEAL SYSTEMS33 citations93

ADVANCED CORNEAL SYSTEMS INC

1 patent

US5866120AFeb 2, 1999

Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase

ADVANCED CORNEAL SYSTEMS INC76 citations92

NUMODA BIOTECHNOLOGIES INC

1 patent

US7977385B2Jul 12, 2011

Agents for corneal or intrastromal administration to treat or prevent disorders of the eye

NUMODA BIOTECHNOLOGIES INC22 citations83

MACKEL MICHAEL JOHN

1 patent

US9896480B2Feb 20, 2018

Integrin receptor antagonists and their methods of use

MACKEL MICHAEL JOHN9 citations78

KARAGEOZIAN VICKEN H

1 patent

US8691874B2Apr 8, 2014

Treatment of ophthalmic disorders using urea

KARAGEOZIAN VICKEN H6 citations78

JENIUS PHARMA LLC

1 patent

US12454549B2Oct 28, 2025

Treatments for diseases and disorders that involve oxidative stress

JENIUS PHARMA LLC0 citations55